Study sees lower chances of Milky Way crashing into Andromeda galaxy
WASHINGTON, June 2 (Reuters) - The Milky Way and the neighboring Andromeda galaxy are currently hurtling through space toward each other at a speed of about 250,000 miles per hour (400,000 kph), setting up a possible future galactic collision that would wreck both of them.
But how likely is this cosmic crash? While previous research forecast it to occur roughly 4-4.5 billion years from now, a new study that uses recent observational data and adds fresh variables indicates that a collision is far from certain. It puts the likelihood of a collision in the next 5 billion years at less than 2% and one in the next 10 billion years at about 50%.
Galactic mergers are not like a demolition derby, with stars and planets crashing into each other, but rather a complicated blending on an immense scale.
"The future collision - if it happens - would be the end of both the Milky Way and Andromeda," said University of Helsinki astrophysicist Till Sawala, lead author of the study published on Monday in the journal Nature Astronomy, opens new tab, with the structure of both being destroyed and a new galaxy with an elliptical shape arising from the merger.
"If a merger happens, it is more likely to occur 7-8 billion years in the future. But we find that based on the current data, we cannot predict the time of a merger, if it happens at all," Sawala said.
The two galaxies currently are around 2.5 billion light-years from each other. A light-year is the distance light travels in a year, 5.9 trillion miles (9.5 trillion km).
The potential collision is so far in the future that Earth by that time is forecast to become a completely different kind of place. Our planet is expected to be rendered uninhabitable roughly a billion years from now, with the sun becoming so hot that it will boil away our planet's oceans.
The sun is one of the Milky Way's many billions of stars. The total mass of our spiral-shaped galaxy - including its stars and interstellar gas as well as its dark matter, which is invisible material whose presence is revealed by its gravitational effects - is estimated at approximately one trillion times the mass of the sun.
The Andromeda galaxy has a shape and total mass similar to the Milky Way's.
The researchers simulated the Milky Way's movement over the next 10 billion years using updated data from the Gaia and Hubble space telescopes and various ground-based telescopes as well as revised galactic mass estimates.
Other nearby galaxies are forecast to factor into whether a collision occurs. Previous research accounted for the gravitational influence of the Triangulum galaxy, also called Messier 33 or M33, which is about half the size of the Milky Way and Andromeda, but did consider the Large Magellanic Cloud, a smaller satellite galaxy of the Milky Way, as this study does.
"We find that if only M33 is added to the two-body system, the chance of a Milky Way-Andromeda merger actually increases, but the inclusion of the Large Magellanic Cloud has the opposite effect," Sawala said.
The researchers concluded that a merger between the Milky Way and the Large Magellanic Cloud is almost certain within the next 2 billion years, long before a potential collision with Andromeda.
One noteworthy difference between the Milky Way and Andromeda is the mass of the supermassive black holes at their centers. The Milky Way's Sagittarius A*, or Sgr A*, is about 4 million times the mass of the sun. Its Andromeda counterpart is about 100 million the sun's mass.
"Collisions between stars are very unlikely, but the two supermassive black holes would sink to the center of the newly formed galaxy, where they would eventually merge," Sawala said.
Galactic mergers have occurred since the universe's early stages and are particularly common in areas of the universe where galaxies are clustered together.
"In the early universe, galaxy mergers were much more frequent, so the first mergers would have occurred very shortly after the first galaxies had formed," Sawala said.
"Minor mergers - with much smaller galaxies - happen more frequently. Indeed, the Milky Way is currently merging with several dwarf galaxies," Sawala said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Guardian
26 minutes ago
- The Guardian
Tim Dowling: the dog has seen my mother-in-law's ghost – or possibly just a bug
The new dog is now a year old, and her bedtime habits are firmly established: when I retire for the night I invariably find the dog already lying on my side of the bed, her chin resting on my pillow. At this point I usually push her off, whereupon she will retreat to her own – perfectly nice – bed, or sleep on the bare floorboards, depending on the night-time temperature. At around five the dog will leap back on to the bed and tunnel under the duvet head-first, stretching out between my wife and me, leaving only her back legs sticking out the top. That's how things remain until one of us decides to get up. It's not ideal, but it's a routine. The daytime routine is looser. The general rhythm is well established – eat, walk, sleep, walk, eat – but there are random moments when the dog seems to require additional, unspecified engagement, when she sits down next to me on the sofa, places a gentle paw on my forearm and gives me a look that says: we need to talk. 'I'm just watching this,' I say, pointing at the television. The dog turns to look at the screen, and then slowly rolls her eyes back toward me. It's easy to read too much into a dog's expression, but at times like these I sense deep wells of frustration. Maybe, I think, she just wants me to change the channel to a show with dogs in it. The next day in the park the dog is lively but obedient, off the lead but never straying out of sight, playful with other dogs but willing to take no for an answer. She behaves perfectly right up until the end, when we encounter a woman in a long coat with two dogs of her own. Shortly after we pass by, my dog suddenly stops, turns and hares off after them. I whistle and call her name, but the dog ignores me and follows the woman – a complete stranger – in the other direction, all the while staring up at her with a look of true devotion. 'Well, we had some good times,' I say, twirling my lead. Eventually the woman is obliged to stop and head back towards me. We meet halfway, my dog still fixated on the woman, who smiles at me and shrugs. 'It's because I have …' I don't quite hear the last word – something like 'spraahtz' – which in the discomfort of the moment I take to be a foreign term for a powerful form of canine magnetism, perhaps as practised in remote parts of Belgium, or maybe Poland. Then the woman reaches out and hands me a tiny dead fish. 'Oh, sprats,' I say. 'They love them,' she says. That evening my wife, my oldest son and I are watching television, while the dog sits next to me and stares at my ear. 'So the take-home message is: we need to get some sprats,' I say. 'I've seen them in the pet store,' my wife says. 'Apparently they can't get enough of them,' I say. 'Be quiet,' she says. 'I'm trying to follow this.' Suddenly the dog barks once, leaps from the sofa, slides across the coffee table and lands on the other side. 'What was that for?' says the oldest one. The dog sits and looks up, staring at nothing with fearsome concentration. 'What is it?' my wife says. 'It's like she's witnessing some kind of apparition,' I say. Perhaps an apparition holding a little dead fish. Sign up to Inside Saturday The only way to get a look behind the scenes of the Saturday magazine. Sign up to get the inside story from our top writers as well as all the must-read articles and columns, delivered to your inbox every weekend. after newsletter promotion 'Have you seen a ghost?' my wife says. 'Is it my mother?' The dog stares, unflinching. 'Actually I think she might just be watching a bug,' I say. 'If it's my mother, give me your paw,' my wife says. The dog takes two steps forward, and places its right paw into my wife's outstretched hand. 'It is my mother!' my wife shouts. The oldest one and I exchange a brief glance as if to say: bit weird. 'Give me your paw again if she misses me,' my wife says. The dog obliges. 'That dog only knows one trick,' the oldest one says. 'And that's it.' 'A tiny hovering insect,' I say. 'Or a baby spider floating on the draught from the windows.' 'Thank you for the message from beyond,' my wife says. 'Now go lie down, I'm trying to watch this.' The dog climbs on to the sofa and curls up next to me, wearing a look of profound dissatisfaction. We watch the telly in silence for a moment. 'So yeah, sprats,' I say. 'Oh my God,' my wife says. 'We'll have to rewind!'
The Guardian
38 minutes ago
- The Guardian
Alzheimer's blood test can spot people with early symptoms, study suggests
A new blood test for Alzheimer's disease can accurately detect people with early symptoms, research suggests. Experts from the Mayo Clinic in the US have provided further evidence that blood tests can work to accurately diagnose dementia by examining two proteins in blood plasma. The proteins – amyloid beta 42/40 and p-tau217 – are associated with amyloid plaque buildup, which is a hallmark of Alzheimer's disease. Researchers found the blood test was highly accurate, with 95% sensitivity, which means it was 95% accurate in picking up people with memory problems, with very few cases missed. It was also 82% for specificity, which means it was also highly accurate in ruling out people without dementia. The study was carried out on more than 500 people in an outpatient memory clinic, meaning it is real-world data. The blood test has been approved by the Food and Drug Administration regulator in the US. Dr Gregg Day, who led the study in the journal Alzheimer's and Dementia, said the test was as good as more invasive tests in use. 'Our study found that blood testing affirmed the diagnosis of Alzheimer's disease with 95% sensitivity and 82% specificity,' he said. 'When performed in the outpatient clinical setting, this is similar to the accuracy of cerebrospinal fluid biomarkers of the disease and is much more convenient and cost-effective.' Overall, researchers found that p-tau217 levels were higher in patients with Alzheimer's disease versus those without the disease. Day said the next steps in the research were to evaluate blood-based testing in more diverse patient populations and people with early Alzheimer's who showed no cognitive symptoms. Dr Richard Oakley, associate director for research and innovation at the Alzheimer's Society in the UK, said the results 'suggest this test is very accurate' and could be used alongside other tests and observations from a trained health professional. 'This study shows how blood tests are making diagnosis of Alzheimer's disease quicker, easier and more accessible than ever before in a real-world setting,' he added. 'While focused on Alzheimer's disease, the test was evaluated in people with other types of dementias too, showing that it may help with differentiate causes of cognitive decline, though more research in diverse groups of individuals and in community-based setting is still needed. 'Currently diagnosis options in the UK are often slow, expensive and can be invasive, meaning thousands miss out on the benefits one can bring. 'It's great to see blood tests like this approved for clinical use in the US. We hope to see the same in the NHS, which is why we're part of the Blood Biomarker Challenge.' The Blood Biomarker Challenge is a multimillion-pound research programme supported by the Alzheimer's Society, Alzheimer's Research UK and the National Institute for Health and Care Research. Its goal is to bring blood tests for dementia diagnosis to the National Health Service by 2029. Oakley said: 'Blood tests will be critical to accelerate diagnosis and give more people access to the care, support and treatments they desperately need faster than ever before. 'We must see long-term investment in the tools and workforce needed to ensure everyone living with dementia can get an early an accurate diagnosis, which is even more important with disease-modifying treatments on the horizon.' Dr Julia Dudley, head of research at Alzheimer's Research UK, said: 'We urgently need to improve how we diagnose dementia and it's great to see international research working towards this goal. 'Blood tests in this study look at p-tau217 and amyloid beta 42/40 and showed the tests offered high accuracy in confirming Alzheimer's disease. 'This study adds to the growing evidence that blood tests can detect the diseases that cause dementia in people with early memory and thinking problems. 'An important point to consider is that people taking part in research don't always reflect the full diversity of those affected by dementia, who might have additional conditions or other characteristics. 'That is why work is needed to understand whether these blood tests work in a real-world setting. 'In the UK, studies like the Blood Biomarker Challenge are helping to build this evidence. The study is testing blood tests, including p-tau217, in thousands of people from sites across the UK. 'This work will be a crucial part of making diagnosis easier and faster, which will bring us closer to a cure.'
Times
4 hours ago
- Times
Church of England must pay priests a proper wage
Act now to keep your subscription We've tried to contact you several times as we haven't been able to take payment. You must update your payment details via My Account or by clicking update payment details to keep your subscription.
